微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Nocardiopsis dassonvillei subsp. dassonvillei (Brocq-Rousseu) Meyer |
|---|---|
| 商品货号： | TS196515 |
| Deposited As： | Nocardia dassonvillei (Brocq-Rousseu) Liegard and Landrieu |
| Strain Designations： | IMRU 509 |
| Application： | Produces restriction endonuclease NdaI Produces xylose isomerase glucose isomerase |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 199: Emerson agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Fleischmann Labs. |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC < |
| References： | Horwath RO, Cole GW. Process for enzymatically isomerizing glucose to fructose. US Patent 3,829,362 dated Aug 13 1974 Roberts RJ. Restriction and modification enzymes and their recognition sequences. Nucleic Acids Res. 13: r165-r200, 1985. PubMed: 2987885 |